Movement Alert|JOINN Rises 5.46% in Regular Trading, Life Sciences Tools and Services Sector Rallies Broadly Driving CRO Rebound

Market Focus08-04

On August 4, JOINN rose 5.46% in regular trading, trading at HK$23.54/share, with turnover of HK$41.78 million.

On the news front, the Life Sciences Tools and Services sector rallied sharply across the board. WuXi AppTec surged 12.65%, GenScript Bio gained 8.1%, Pharmaron rose 7.49%, WuXi XDC climbed 5.94%, and WuXi Bio advanced 4.79%, with broad-based gains across the sector.

The rally was underpinned by multiple leading CRO companies reporting significant growth in new order signings during the first quarter, with industry order recovery momentum continuing. Additionally, JOINN had previously confirmed that the supply-demand balance for non-human primate experimental animals remains tight, with prices rising compared to prior periods. Separately, institutions have noted that CXO sector prosperity has entered an earnings delivery phase, with first-half performance pre-announcements from several peers showing substantial profit growth, providing fundamental support for the sector-wide rally.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment